Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 60, Issue 9, Pages 621-628Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2006.07.092
Keywords
cancer immunotherapy/CTL; NK; antibody based therapy/tumour associated antigens (TAAs)
Ask authors/readers for more resources
Since the last two decades, rapid progress has been made in the field of cancer immunotherapy relevant to manipulation of adaptative cytotoxic T lymphocytes (CTLs) and innate immunity natural killer (NK) cells as well as antibodies. Many possibilities are now offered for therapeutic purposes contributing to better approaches in treatment of cancer. (c) 2006 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
